Home » Healthcare » Autoimmune Diseases Diagnostics Market

Autoimmune Diseases Diagnostics By Disease Type (Systemic Autoimmune Disease, Localized Autoimmune Disease) By Test Type (Antinuclear Antibody Test, Autoantibody Test, C-reactive (CRP), Complete Blood Count (CBC), Urinalysis, Others) By End Use (Hospitals, Diagnostics Centers, Others)Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the report

How are the major segments performing in the Autoimmune Diseases Diagnostics market?

In 2022, systemic autoimmune disease diagnosis is anticipated to experience the highest CAGR growth among the two sectors over the forecast period. The expansion of promising government programs, especially the AMP RA/SLE program for people with rheumatoid arthritis and systemic lupus erythematosus, is credited with driving this market.
In 2022, according to test type, the market for diagnosing autoimmune diseases was dominated by antinuclear antibody testing. The high frequency of immune system-damaging conditions such as type 1 diabetes, myasthenia gravis, Addison’s disease, rheumatoid arthritis, etc., is largely responsible for this market’s dominating rise.
In 2022, the autoimmune disease diagnostics market is anticipated to dominate the hospital sector because hospitals provide comprehensive care, including diagnosis, treatment, procedures, and physiotherapy, and patients like hospitals, which is reflected in their high preference for hospitals and the size of their market share.

What is the Market Size of Autoimmune Diseases Diagnostics regarding value?

The global Autoimmune Diseases Diagnostics market is anticipated to grow at a substantial CAGR of 7.5% in the upcoming years. The global Autoimmune Diseases Diagnostics industry was estimated to be worth USD 4.8 billion in 2022 and was expected to be worth USD 7.96 billion by 2030.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Which region dominated the Autoimmune Diseases Diagnostics market?

An autoimmune disease diagnostics market analysis predicts North America will produce the highest revenue and grow at the quickest CAGR during the forecast period. Its growth is brought on by the accessibility of numerous improved and more trustworthy disease diagnosis processes, the quick uptake of numerous advanced diagnostic techniques, and continuous technological advancements in the healthcare industry. The national market for autoimmune disease diagnostics is expanding economically, thanks largely to awareness initiatives run by various groups. The regional market is expanding due to rising consumer desires for more sophisticated sickness diagnosis technologies and the healthcare sector’s quick expansion.

How US Market is Performing in the Autoimmune Diseases Diagnostics market?

The US is predicted to have the greatest share of the global market for autoimmune disease diagnostics due to the rising prevalence of autoimmune illnesses like rheumatoid arthritis, rising financial support from public and private organizations, and the adoption of cutting-edge technologies. In addition, encouraging government initiatives and growing awareness would support the market expansion. Modernized diagnostic facilities and automation technology in diagnosis and treatment would offer significant growth possibilities. Furthermore, it is projected that the introduction of novel products and the presence of major international players will improve regional market statistics. Because of the advent of the Affordable Care Act, the existence of helpful laws and activities carried out by the AARDA and the high prevalence of diseases in the area. Over 50 million Americans suffer from an autoimmune condition, according to AARDA. A high prevalence of chronic diseases and rising healthcare costs have prompted the government and other business-friendly groups to introduce beneficial measures. By early disease diagnosis and increased patient awareness, these programs seek to reduce healthcare spending.

How is the economy impacting global Autoimmune Diseases Diagnostics growth?

The general economic climate in different regions might impact the global market for autoimmune disease diagnostics. While a weak economy may result in lower healthcare spending and slower growth of the diagnostics business, a strong economy can support more healthcare spending, including diagnostic testing and therapies for autoimmune illnesses. The price of diagnosing autoimmune illnesses might also have a big impact on the market’s expansion. Patients and healthcare providers may be less inclined to spend money on expensive diagnostics in areas with greater healthcare expenditures, which could restrain the market’s expansion. It’s important to remember that autoimmune diseases are chronic ailments, and regardless of the state of the economy, the demand for diagnostics for these conditions is anticipated to stay mostly stable. Moreover, the prevalence of autoimmune disorders is rising internationally, which is projected to continue fueling the demand for autoimmune disease diagnostics.

What is the competitive environment of the Autoimmune Diseases Diagnostics market?

The competitive environment information for the Autoimmune Diseases Diagnostics market includes information on the global market share, a summary of the business structure, the introduction of new products, and the potential for the industrial Autoimmune Diseases Diagnostics market. It also provides data on the overall economic profit generated by suppliers and companies. Due to low-cost manufacturing procedures, simple access to raw materials, and lenient production limits, the industry is actively populated by both domestic and foreign enterprises. To diagnose systemic lupus erythematosus, systemic sclerosis, polymyositis & dermatomyositis, respectively, Inova approved their QUANTA Flash dsDNA, Scl-70 tests, and Jo-1 range of assays.

Executive Summary

What are the key trends in the Autoimmune Diseases Diagnostics market?

Rheumatoid arthritis is an autoimmune condition primarily targeting the synovial tissues within the joints (RA). Those who are elderly are more likely to get the illness. The aging population and technological improvements have also significantly increased the CAGR of the global autoimmune disease diagnostics market in recent years.
With the increase in the burden of the senior population, Rheumatoid arthritis is a common disease being diagnosed in the aging population; there is a high risk of an upsurge of rheumatoid arthritis, thus driving the growth in autoimmune disease diagnostics market revenue.

How are Manufacturers Teaming Up with Stakeholders in the Autoimmune Diseases Diagnostics Market?

To improve their product offerings and broaden their reach, manufacturers in the autoimmune diseases diagnostics market are collaborating with numerous stakeholders. Manufacturers are working with healthcare providers like hospitals, clinics, and laboratories to increase patient access to diagnostic testing. Manufacturers may reach a larger market and guarantee that patients obtain correct and quick diagnoses by collaborating with these stakeholders. Manufacturers and research organizations collaborate to create new diagnostic technologies and test procedures. By working with these stakeholders, manufacturers may acquire cutting-edge research and maintain a competitive edge. Manufacturers are working with patient advocacy organizations to spread knowledge about autoimmune illnesses and the value of early diagnosis. Through these partnerships, manufacturers can better comprehend patient demands and develop goods that better suit those needs.

Which are the key investments by the Autoimmune Diseases Diagnostics market players?

Leading companies in the market for autoimmunity disease diagnostics are concentrating on increasing their production capabilities. To serve more domestic end users and gain a competitive advantage, players also emphasize strategic alliances and partnerships and increase farmers’ knowledge through various associations established to encourage smart farming approaches. For illustration, Invisible Sentinel, a business with headquarters in the United States, was purchased by BioMérieux SA in July 2020. This business specializes in analyzing food and drink molecules.

Some major players in the Autoimmune Diseases Diagnostics market are Abbott Laboratories, Biomerieux, Bio-rad Laboratories, Euroimmun AG, F. Hoffmann-la Roche, Inova Diagnostics Inc., Myriad Genetics, Siemens Healthineers Inc., Thermo Fisher Scientific, Trinity Biotech, Grifols S.A., Exagen Inc., DIAsource ImmunoAssays SA, R-Biopharm AG.

What are the Major Driving Factors for the Autoimmune Diseases Diagnostics Market?

The rising prevalence of diseases and illnesses, including Hashimoto’s thyroiditis and rheumatoid arthritis, and the extension of governmental legislation supporting these conditions will substantially impact the autoimmune disease diagnostics sector. More product introductions and an increase in the number of growth strategies employed by key firms will result in a larger market. Yet, the most recent technical developments allow for the measurement and identification of many antibodies all at once. Mass spectrometry and antigen microarray for antibody profiling are only two examples of the many techniques that have experienced improvements in analytical sensitivity and reproducibility. Automated testing methods such as indirect immunofluorescence, monoplex immunoassays, and multiplex immunoassays will also cut down on testing times. The Asia Pacific areas’ rising opportunities are also due to their vast development potential and sizable patient base. As the number of research projects rises, the top competitors in the market should find a number of opportunities for revenue generation. One of the factors influencing the market’s growth is rising awareness. One of the main causes of autoimmune illnesses is stress. Other prominent causes include genetic alterations, poor dietary habits, and environmental variables. The growing prevalence of autoimmune disorders worldwide increases the demand for autoimmune disease diagnostics. For instance, around 1.4 million Americans have Type-1 diabetes, according to the CDC National Diabetes Statistical Report, 2020. By 2040, this figure is projected to rise to 2.1 million. The initiatives performed by numerous governmental and private organizations are also responsible for a rise in public knowledge regarding the diagnosis and treatment of autoimmune disorders. For instance, the Autoimmune Association (U.S.) organizes activities and campaigns annually throughout March to enhance public understanding of autoimmune disorders.

What are the Major Risks for the Autoimmune Diseases Diagnostics Market?

The absence of proper compensation for diagnostic tests is one of the major threats to the autoimmune disorders diagnostics market. Regional and national differences in insurance coverage and payment practices may impact the pricing and accessibility of autoimmune disease testing. The high cost of testing poses another danger to the autoimmune disorders diagnostics sector. Because they are expensive, cutting-edge diagnostic technologies like next-generation sequencing, proteomics, and metabolomics may not be used as frequently in everyday clinical practice. Diagnosing autoimmune diseases can be difficult because they are a diverse and complex collection of illnesses. Lack of knowledge of these illnesses among medical professionals and patients may lead to delayed or incorrect diagnoses, affecting the demand for diagnostic testing.

Which is the key test type in the Autoimmune Diseases Diagnostics market?

The market for autoimmune disease diagnostics is divided into various test categories, including antinuclear antibody tests, autoantibody testing, c-reactive protein (CRP), complete blood count (CBC), urinalysis, and others, based on the type of test used. The high frequency of immune system-damaging conditions such as type 1 diabetes, myasthenia gravis, Addison’s disease, rheumatoid arthritis, etc., is largely responsible for this market’s dominating rise. Antinuclear antibodies are found in the blood through antinuclear antibody testing. An autoimmune condition with a genetic susceptibility is myasthenia gravis. Myasthenia gravis frequency in the United States was around 20 cases per 100,000 people in 2021, and it is steadily rising, according to NCBI. Therefore, it is anticipated that the autoimmune disease diagnostics industry landscape is due to the increased frequency of hereditary autoimmune illnesses.

How is the Autoimmune Diseases Diagnostics market performing in regions?

Due to the rising prevalence of autoimmune illnesses and increased knowledge of their diagnosis, Asia-Pacific is predicted to have significant market expansion over the forecast period. The market is also expanding as a result of the strategic actions made by market participants, more research, and growing healthcare infrastructure. Psoriasis, rheumatoid arthritis, and inflammatory bowel disease are a few examples of autoimmune, inflammatory, and pulmonary diseases that are becoming more prevalent in the Asia Pacific, according to a June 2022 article by Janssen Asia Pacific, a division of Johnson & Johnson Pte. Ltd. In addition to having the highest frequency of systemic lupus erythematosus (SLE) in China and Southeast Asia, the region already has the highest burden of chronic obstructive pulmonary disease in the entire world. Hence, in the upcoming years, there will probably be a demand for diagnostics.

What is the regulatory landscape for the Autoimmune Diseases Diagnostics market?

The regulatory environment for the market for diagnostics for autoimmune diseases differs by region and nation. In order to assure the safety and efficacy of these tests, several regulatory regulations and guidelines generally apply to the development and marketing of diagnostic tests for autoimmune illnesses. The Federal Food, Drug, and Cosmetic Act governs how the Food and Drug Administration (FDA) in the United States regulates autoimmune disease diagnostic procedures (FDCA). These tests are categorised by the FDA as in vitro diagnostic devices (IVDs), and their commercialization requires clearance or approval from the FDA. The In Vitro Diagnostic Regulation (IVDR), which went into effect in May 2022, governs diagnostic procedures for autoimmune illnesses in the European Union. The In Vitro Diagnostic Directive was replaced by the IVDR, which places stronger regulations on the creation, testing, and marketing of IVDs (IVDD).

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the major players planning for the future of the Autoimmune Diseases Diagnostics market?

A blood test to identify an antigen associated with the autoimmune blistering condition known as mucous membrane pemphigoid (MMP), which frequently results in painful sores in the oral cavity, was introduced by KSL Beutner Laboratories (Beutner) in August 2022. Thermofisher’s new Phadia 2500+ range of devices will be accessible for autoimmune testing in the US starting in May 2022. It provides dependable and unmatched high throughput for autoimmune and allergy tests.

REPORT ATTRIBUTE	DETAILS
Autoimmune Diseases Diagnostics Market by Volume	Yes
Autoimmune Diseases Diagnostics Market by Value	Yes
Autoimmune Diseases Diagnostics Market, Tornado Analysis	Yes
Autoimmune Diseases Diagnostics Market, STAR Analysis	Yes
Autoimmune Diseases Diagnostics Market, SRC Analysis	Yes
Autoimmune Diseases Diagnostics Market, Import-Export Data	Yes (On Demand)
Autoimmune Diseases Diagnostics Market Pricing Analysis	Yes (On Demand)
Autoimmune Diseases Diagnostics Market Segment Analysis	By Disease Type (Systemic Autoimmune Disease, Localized Autoimmune Disease) By Test Type (Antinuclear Antibody Test, Autoantibody Test, C-reactive (CRP), Complete Blood Count (CBC), Urinalysis, Others) By End Use (Hospitals, Diagnostics Centers, Others)
Autoimmune Diseases Diagnostics Market, Regional Analysis	North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and Rest of Middle East and Africa)
Autoimmune Diseases Diagnostics Market Key Companies	Abbott Laboratories, Biomerieux, Bio-rad Laboratories, Euroimmun AG, F. Hoffmann-la Roche, Inova Diagnostics Inc., Myriad Genetics, Siemens Healthineers Inc., Thermo Fisher Scientific, Trinity Biotech, Grifols S.A., Exagen Inc., DIAsource ImmunoAssays SA, R-Biopharm AG
Autoimmune Diseases Diagnostics Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

Segmentation of Global Autoimmune Diseases Diagnostics Market-

Global Autoimmune Diseases Diagnostics Market – By Disease Type

Systemic Autoimmune Disease
Localized Autoimmune Disease

Global Autoimmune Diseases Diagnostics Market – By Test Type

Antinuclear Antibody Test
Autoantibody Test
C-reactive (CRP)
Complete Blood Count (CBC)
Urinalysis
Others

Global Autoimmune Diseases Diagnostics Market – By End-User

Hospitals
Diagnostics Centres
Others

Global Autoimmune Diseases Diagnostics Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Autoimmune Diseases Diagnostics Market
2.2. Global Autoimmune Diseases Diagnostics Market, By Disease Type
2.3. Global Autoimmune Diseases Diagnostics Market, By Test Type
2.4. Global Autoimmune Diseases Diagnostics Market, By End-User
2.5. Global Autoimmune Diseases Diagnostics Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Autoimmune Diseases Diagnostics Market Value, 2023-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Disease Type
3.5.2. Test Type
3.5.3. End User
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Methods
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Autoimmune Diseases Diagnostics Market
7.1. Global Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030(US$ Bn)
7.1.1. Overview
7.1.2. Global Autoimmune Diseases Diagnostics Market, By Disease Type, 2022 vs 2030 (in%)
7.1.3. Global Autoimmune Diseases Diagnostics Market, By Systemic Autoimmune Disease, 2023-2030 (US$ Bn)
7.1.4. Global Autoimmune Diseases Diagnostics Market, By Localized Autoimmune Disease, 2023-2030 (US$ Bn)
7.2. Global Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030(US$ Bn)
7.2.1. Overview
7.2.2. Global Autoimmune Diseases Diagnostics Market, By Test Type, 2022 vs 2030 (in%)
7.2.3. Global Autoimmune Diseases Diagnostics Market, By Antinuclear Antibody Test, 2023-2030 (US$ Bn)
7.2.4. Global Autoimmune Diseases Diagnostics Market, By Autoantibody Test, 2023-2030 (US$ Bn)
7.2.5. Global Autoimmune Diseases Diagnostics Market, By C-reactive (CRP), 2023-2030 (US$ Bn)
7.2.6. Global Autoimmune Diseases Diagnostics Market, By Complete Blood Count (CBC), 2023-2030 (US$ Bn)
7.2.7. Global Autoimmune Diseases Diagnostics Market, By Urinalysis, 2023-2030 (US$ Bn)
7.2.8. Global Autoimmune Diseases Diagnostics Market, By Others, 2023-2030 (US$ Bn)

7.3. Global Autoimmune Diseases Diagnostics Market, by Product End-User, 2023-2030(US$ Bn)
7.3.1. Overview
7.3.2. Global Autoimmune Diseases Diagnostics Market, By End-User, 2022 vs 2030 (in%)
7.3.3. Global Autoimmune Diseases Diagnostics Market, By Hospitals, 2023-2030 (US$ Bn)
7.3.4. Global Autoimmune Diseases Diagnostics Market, By Diagnostics Centers, 2023-2030 (US$ Bn)
7.3.5. Global Autoimmune Diseases Diagnostics Market, By Others, 2023-2030 (US$ Bn)

8. North America Autoimmune Diseases Diagnostics Market Analysis
8.1. North America Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
8.4.1.2. U.S. Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
8.4.1.3. U.S. Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
8.4.1.4. U.S. Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
8.4.2.2. Canada Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
8.4.2.3. Canada Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
8.4.2.4. Canada Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)

9. Europe Autoimmune Diseases Diagnostics Market Analysis
9.1. Europe Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
9.4.1.2. Germany Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
9.4.1.3. Germany Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
9.4.1.4. Germany Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
9.4.2. France
9.4.2.1. France Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
9.4.2.2. France Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
9.4.2.3. France Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
9.4.2.4. France Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
9.4.3.2. UK Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
9.4.3.3. UK Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
9.4.3.4. UK Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
9.4.3.5.
9.4.4. Italy
9.4.4.1. Italy Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
9.4.4.2. Italy Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
9.4.4.3. Italy Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
9.4.4.4. Italy Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
9.4.5.2. Spain Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
9.4.5.3. Spain Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
9.4.5.4. Spain Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
9.4.6.2. Rest of Europe Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
9.4.6.3. Rest of Europe Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
9.4.6.4. Rest of Europe Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)

10. Asia Pacific Autoimmune Diseases Diagnostics Market Analysis
10.1. Asia Pacific Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
10.4.1. China
10.4.1.1. China Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
10.4.1.2. China Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
10.4.1.3. China Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
10.4.1.4. China Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
10.4.2.2. Japan Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
10.4.2.3. Japan Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
10.4.2.4. Japan Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
10.4.3. India
10.4.3.1. India Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
10.4.3.2. India Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
10.4.3.3. India Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
10.4.3.4. India Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
10.4.4.2. South Korea Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
10.4.4.3. South Korea Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
10.4.4.4. South Korea Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
10.4.5.2. South-East Asia Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
10.4.5.3. South-East Asia Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
10.4.5.4. South-East Asia Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)

11. Latin America Autoimmune Diseases Diagnostics Market Analysis
11.1. Latin America Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
11.4.1.2. Brazil Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
11.4.1.3. Brazil Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
11.4.1.4. Brazil Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
11.4.2.2. Mexico Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
11.4.2.3. Mexico Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
11.4.2.4. Mexico Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
11.4.3.2. Rest of Latin America Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
11.4.3.3. Rest of Latin America Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
11.4.3.4. Rest of Latin America Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)

12. Middle East and Africa Autoimmune Diseases Diagnostics Market Analysis
12.1. Middle East and Africa Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
12.4.1.2. GCC Countries Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
12.4.1.3. GCC Countries Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
12.4.1.4. GCC Countries Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
12.4.2.2. South Africa Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
12.4.2.3. South Africa Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
12.4.2.4. South Africa Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Autoimmune Diseases Diagnostics Market Estimates and Forecast, 2023-2030 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Autoimmune Diseases Diagnostics, By Disease Type, 2023-2030 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Autoimmune Diseases Diagnostics, By Test Type, 2023-2030 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Autoimmune Diseases Diagnostics, By End-User, 2023-2030 (US$ Bn)

13. Company Profiles
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Biomerieux
13.3. Bio-rad Laboratories
13.4. Euroimmun AG
13.5. F. Hoffmann-la Roche
13.6. Inova Diagnostics Inc.
13.7. Myriad Genetics
13.8. Siemens Healthineers Inc.
13.9. Thermo Fisher Scientific
13.10. Trinity Biotech
13.11. Others

List of Figures

FIG. 1 Global Autoimmune Diseases Diagnostics Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Autoimmune Diseases Diagnostics Market Segmentation
FIG. 4 Global Autoimmune Diseases Diagnostics Market, by Disease Type, 2022 (US$ Bn)
FIG. 5 Global Autoimmune Diseases Diagnostics Market, by Test Type, 2022 (US$ Bn)
FIG. 6 Global Autoimmune Diseases Diagnostics Market, by End-User, 2022 (US$ Bn)
FIG. 7 Global Autoimmune Diseases Diagnostics Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Disease Type, 2022
FIG. 9 Attractive Investment Proposition, by Test Type, 2022
FIG. 10 Attractive Investment Proposition, by End-User, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key Autoimmune Diseases Diagnostics Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key Autoimmune Diseases Diagnostics Market Manufacturers, 2022
FIG. 14 Global Autoimmune Diseases Diagnostics Market Value Contribution, By Disease Type, 2022 & 2030 (Value %)
FIG. 15 Global Autoimmune Diseases Diagnostics Market, by Systemic Autoimmune Disease, Value, 2023-2030 (US$ Bn)
FIG. 16 Global Autoimmune Diseases Diagnostics Market, by Localized Autoimmune Disease, Value, 2023-2030 (US$ Bn)
FIG. 17 Global Autoimmune Diseases Diagnostics Market, by Powder, Value, 2023-2030 (US$ Bn)
FIG. 18 Global Autoimmune Diseases Diagnostics Market, by Gaskets, Value, 2023-2030 (US$ Bn)
FIG. 19 Global Autoimmune Diseases Diagnostics Market, by Plates and Sheets, Value, 2023-2030 (US$ Bn)
FIG. 20 Global Autoimmune Diseases Diagnostics Market, by Others, Value, 2023-2030 (US$ Bn)
FIG. 21 Global Autoimmune Diseases Diagnostics Market Value Contribution, By Test Type, 2022 & 2030 (Value %)
FIG. 22 Global Autoimmune Diseases Diagnostics Market, By Antinuclear Antibody Test, Value, 2023-2030 (US$ Bn)
FIG. 23 Global Autoimmune Diseases Diagnostics Market, Autoantibody Test, Value, 2023-2030 (US$ Bn)
FIG. 24 Global Autoimmune Diseases Diagnostics Market, C-reactive (CRP), Value, 2023-2030 (US$ Bn)
FIG. 25 Global Autoimmune Diseases Diagnostics Market, Complete Blood Count (CBC), Value, 2023-2030 (US$ Bn)
FIG. 26 Global Autoimmune Diseases Diagnostics Market, Urinalysis, Value, 2023-2030 (US$ Bn)
FIG. 27 Global Autoimmune Diseases Diagnostics Market, by Others, Value, 2023-2030 (US$ Bn)
FIG. 28 Global Autoimmune Diseases Diagnostics Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 29 Global Autoimmune Diseases Diagnostics Market, By Hospitals, Value, 2023-2030 (US$ Bn)
FIG. 30 Global Autoimmune Diseases Diagnostics Market, Diagnostics Centers, Value, 2023-2030 (US$ Bn)
FIG. 31 Global Autoimmune Diseases Diagnostics Market, by Others, Value, 2023-2030 (US$ Bn)
FIG. 32 nORTH America Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 33 U.S. Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 34 Canada Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 35 Europe Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 36 Germany Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 37 France Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 38 U.K. Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 39 Italy Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 40 Spain Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 41 Rest of Europe Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 42 Asia Pacific Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 43 China Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 44 Japan Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 45 India Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 46 South Korea Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 47 Southeast Asia Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 48 Rest of Asia Pacific Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 49 Latin America Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 50 Brazil Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 51 Mexico Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 52 Rest of Latin America Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 53 Middle East & Africa Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 54 GCC Countries Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 55 South Africa Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)
FIG. 56 Rest of Middle East and Africa Autoimmune Diseases Diagnostics Market, 2023-2030 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Autoimmune Diseases Diagnostics Market
TABLE 2 Global Autoimmune Diseases Diagnostics Market, by Competitive Benchmarking, 2022
TABLE 3 Global Autoimmune Diseases Diagnostics Market, by Geographical Presence Analysis, 2022
TABLE 4 Global Autoimmune Diseases Diagnostics Market, by Key Strategies Analysis, 2022
TABLE 5 Global Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 6 Global Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 7 Global Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 8 Global Autoimmune Diseases Diagnostics Market, by Geography, 2023-2030 (US$ Bn)
TABLE 9 North America Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 10 North America Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 11 North America Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 12 North America Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 13 US Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 14 US Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 15 US Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 16 Canada Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 17 Canada Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 18 Canada Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 19 Europe Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 20 Europe Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 21 Europe Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 22 Europe Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 23 Germany Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 24 Germany Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 25 Germany Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 26 France Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 27 France Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 28 France Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 29 UK Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 30 UK Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 31 UK Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 32 Italy Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 33 Italy Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 34 Italy Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 35 Spain Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 36 Spain Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 37 Spain Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 38 Rest of Europe Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 39 Rest of Europe Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 40 Rest of Europe Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 41 Asia Pacific Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 42 Asia Pacific Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 43 Asia Pacific Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 44 Asia Pacific Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 45 China Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 46 China Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 47 China Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 48 Japan Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 49 Japan Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 50 Japan Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 51 India Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 52 India Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 53 India Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 54 South Korea Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 55 South Korea Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 56 South Korea Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 57 South East Asia Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 58 South East Asia Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 59 South East Asia Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 60 Rest of Asia Pacific Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 61 Rest of Asia Pacific Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 62 Rest of Asia Pacific Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 63 Latin America Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 64 Latin America Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 65 Latin America Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 66 Latin America Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 67 Brazil Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 68 Brazil Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 69 Brazil Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 70 Mexico Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 71 Mexico Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 72 Mexico Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 73 Rest of Latin America Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 74 Rest of Latin America Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 75 Rest of Latin America Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 76 Middle East and Africa Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 77 Middle East and Africa Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 78 Middle East and Africa Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 79 Middle East and Africa Autoimmune Diseases Diagnostics Market, by Country, 2023-2030 (US$ Bn)
TABLE 80 GCC Countries Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 81 GCC Countries Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 82 GCC Countries Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 83 South Africa Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 84 South Africa Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 85 South Africa Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Autoimmune Diseases Diagnostics Market, by Disease Type, 2023-2030 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Autoimmune Diseases Diagnostics Market, by Test Type, 2023-2030 (US$ Bn)
TABLE 88 Rest of Middle East and Africa Autoimmune Diseases Diagnostics Market, by End-User, 2023-2030 (US$ Bn)

Frequently Asked Questions

How does COVID-19 Impact the global Autoimmune Diseases Diagnostics market?

COVID-19 has had a substantial impact on the market due to the outbreak of the COVID-19 pandemic, which reduced the demand for Autoimmune Diseases Diagnostics from its commercial application.

Which is the leading region of the market for Autoimmune Diseases Diagnostics?

North America accounted for the most heightened share in the global Autoimmune Diseases Diagnostics market.

What are the key drivers for the growth of the Autoimmune Diseases Diagnostics market?

The rising prevalence of diseases and illnesses, including Hashimoto’s thyroiditis and rheumatoid arthritis.

Which is the major segment in the Autoimmune Diseases Diagnostics market by disease type?

The Systemic Autoimmune Disease segment had a major share in the global market in 2022.

Which is the major segment in the Autoimmune Diseases Diagnostics market by test type?

The Antinuclear Antibody Test segment had a major share in the global market.

Which is the major segment in the Autoimmune Diseases Diagnostics market by end-user?

The hospital segment had a major share in the global market.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –